Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 1629236, 7 pages
http://dx.doi.org/10.1155/2016/1629236
Research Article

Role of miRNAs in Epicardial Adipose Tissue in CAD Patients with T2DM

1Medicine Department, Shihezi University, Shihezi, Xinjiang 832000, China
2Department of Cardiology, People’s Hospital of Xinjiang Uygur Autonomous Region, Urumqi, Xinjiang 830000, China
3Department of Thoracic and Cardiovascular Surgery, The First Affiliated Hospital of Shihezi University School of Medicine, Shihezi, Xinjiang 832008, China

Received 17 March 2016; Accepted 26 June 2016

Academic Editor: Vinicio A. de Jesus Perez

Copyright © 2016 Yang Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Coutinho, H. C. Gerstein, Y. Wang, and S. Yusuf, “The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years,” Diabetes Care, vol. 22, no. 2, pp. 233–240, 1999. View at Publisher · View at Google Scholar · View at Scopus
  2. D. K. Song, Y. S. Hong, H. Lee, J.-Y. Oh, Y.-A. Sung, and Y. Kim, “Increased epicardial adipose tissue thickness in type 2 diabetes mellitus and Obesity,” Diabetes and Metabolism Journal, vol. 39, no. 5, pp. 405–413, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. D. S. Mohar, J. Salcedo, K. C. Hoang et al., “Epicardial adipose tissue volume as a marker of coronary artery disease severity in patients with diabetes independent of coronary artery calcium: Findings from the CTRAD Study,” Diabetes Research and Clinical Practice, vol. 106, no. 2, pp. 228–235, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. T. Mazurek, L. Zhang, A. Zalewski et al., “Human epicardial adipose tissue is a source of inflammatory mediators,” Circulation, vol. 108, no. 20, pp. 2460–2466, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. G. Iacobellis and F. Leonetti, “Epicardial adipose tissue and insulin resistance in obese subjects,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 11, pp. 6300–6302, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. E. M. Akbas, H. Hamur, L. Demirtas et al., “Predictors of epicardial adipose tissue in patients with type 2 diabetes mellitus,” Diabetology and Metabolic Syndrome, vol. 6, no. 1, article 55, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. A. R. Baker, N. F. D. Silva, D. W. Quinn et al., “Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease,” Cardiovascular Diabetology, vol. 5, article 1, 2006. View at Google Scholar · View at Scopus
  8. Y. Xu, X. Cheng, K. Hong, C. Huang, and L. Wan, “How to interpret epicardial adipose tissue as a cause of coronary artery disease: a meta-analysis,” Coronary Artery Disease, vol. 23, no. 4, pp. 227–233, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. A. M. Noyes, K. Dua, R. Devadoss, and L. Chhabra, “Cardiac adipose tissue and its relationship to diabetes mellitus and cardiovascular disease,” World Journal of Diabetes, vol. 5, no. 6, pp. 868–876, 2014. View at Publisher · View at Google Scholar
  10. G. Iacobellis and A. C. Bianco, “Epicardial adipose tissue: emerging physiological, pathophysiological and clinical features,” Trends in Endocrinology and Metabolism, vol. 22, no. 11, pp. 450–457, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. G. Iacobellis, D. Corradi, and A. M. Sharma, “Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart,” Nature Clinical Practice Cardiovascular Medicine, vol. 2, no. 10, pp. 536–543, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. C.-P. Wang, H.-L. Hsu, W.-C. Hung et al., “Increased Epicardial Adipose Tissue (EAT) volume in type 2 diabetes mellitus and association with metabolic syndrome and severity of coronary atherosclerosis,” Clinical Endocrinology, vol. 70, no. 6, pp. 876–882, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Srinivasan, S. T. Selvan, G. Archunan, B. Gulyas, and P. Padmanabhan, “MicroRNAs -the next generation therapeutic targets in human diseases,” Theranostics, vol. 3, no. 12, pp. 930–942, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. S. M. Grundy, J. I. Cleeman, C. N. B. Merz et al., “Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines,” Journal of the American College of Cardiology, vol. 44, no. 3, pp. 720–732, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. H. L. Fu, D. P. Wu, X. F. Wang et al., “Altered miRNA expression is associated with differentiation, invasion, and metastasis of esophageal squamous cell carcinoma (ESCC) in patients from Huaian, China,” Cell Biochemistry and Biophysics, vol. 67, no. 2, pp. 657–668, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. D. W. Huang, B. T. Sherman, and R. A. Lempicki, “Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists,” Nucleic Acids Research, vol. 37, no. 1, pp. 1–13, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. D. W. Huang, B. T. Sherman, Q. Tan et al., “DAVID bioinformatics resources: expanded annotation database and novel algorithms to better extract biology from large gene lists,” Nucleic Acids Research, vol. 35, no. 2, pp. W169–W175, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. D. W. Huang, B. T. Sherman, Q. Tan et al., “The DAVID gene functional classification tool: a novel biological module-centric algorithm to functionally analyze large gene lists,” Genome Biology, vol. 8, no. 9, article R183, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. E. I. Boyle, S. Weng, J. Gollub et al., “GO::TermFinder—open source software for accessing Gene Ontology information and finding significantly enriched Gene Ontology terms associated with a list of genes,” Bioinformatics, vol. 20, no. 18, pp. 3710–3715, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Cheng, S. Sun, A. Tracy et al., “NetAffix gene ontology mining tool: a visual approach for microarray data analysis,” Bioinformatics, vol. 20, no. 9, pp. 1462–1463, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. L. J. Jensen, M. Kuhn, M. Stark et al., “STRING 8-a global view on proteins and their functional interactions in 630 organisms,” Nucleic Acids Research, vol. 37, no. 1, pp. D412–D416, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. D. Szklarczyk, A. Franceschini, M. Kuhn et al., “The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored,” Nucleic Acids Research, vol. 39, no. 1, pp. D561–D568, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. T. M. Motawae, M. F. Ismail, M. I. Shabayek, and M. M. Seleem, “MicroRNAs 9 and 370 association with biochemical markers in T2D and CAD complication of T2D,” PLoS ONE, vol. 10, no. 5, article e0126957, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. D. S. Karolina, S. Tavintharan, A. Armugam et al., “Circulating miRNA profiles in patients with metabolic syndrome,” Journal of Clinical Endocrinology and Metabolism, vol. 97, no. 12, pp. E2271–E2276, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. E. Bronze-Da-Rocha, “MicroRNAs expression profiles in cardiovascular diseases,” BioMed Research International, vol. 2014, Article ID 985408, 23 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Etheridge, I. Lee, L. Hood, D. Galas, and K. Wang, “Extracellular microRNA: a new source of biomarkers,” Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesi, vol. 717, no. 1-2, pp. 85–90, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. C. Herder, M. Karakas, and W. Koenig, “Biomarkers for the prediction of type 2 diabetes and cardiovascular disease,” Clinical Pharmacology and Therapeutics, vol. 90, no. 1, pp. 52–66, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Vacca, M. Di Eusanio, M. Cariello et al., “Integrative miRNA and whole-genome analyses of epicardial adipose tissue in patients with coronary atherosclerosis,” Cardiovascular Research, vol. 109, no. 2, pp. 228–239, 2016. View at Publisher · View at Google Scholar
  29. F. Wang, G. Long, C. Zhao et al., “Plasma microRNA-133a is a new marker for both acute myocardial infarction and underlying coronary artery stenosis,” Journal of Translational Medicine, vol. 11, no. 1, article 222, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Hoekstra, C. A. C. van der Lans, B. Halvorsen et al., “The peripheral blood mononuclear cell microRNA signature of coronary artery disease,” Biochemical and Biophysical Research Communications, vol. 394, no. 3, pp. 792–797, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Kremen, M. Dolinkova, J. Krajickova et al., “Increased subcutaneous and epicardial adipose tissue production of proinflammatory cytokines in cardiac surgery patients: possible role in postoperative insulin resistance,” The Journal of Clinical Endocrinology & Metabolism, vol. 91, no. 11, pp. 4620–4627, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. J. M. Marchington, C. A. Mattacks, and C. M. Pond, “Adipose tissue in the mammalian heart and pericardium: structure, foetal development and biochemical properties,” Comparative Biochemistry and Physiology—Part B, vol. 94, no. 2, pp. 225–232, 1989. View at Publisher · View at Google Scholar · View at Scopus
  33. B. Gaborit, N. Venteclef, P. Ancel et al., “Human epicardial adipose tissue has a specific transcriptomic signature depending on its anatomical peri-atrial, peri-ventricular, or peri-coronary location,” Cardiovascular Research, vol. 108, no. 1, pp. 62–73, 2015. View at Publisher · View at Google Scholar · View at Scopus